Glenmark Pharma receives USFDA approval for clobetasol propionate
Glenmark Pharmaceuticals has received USFDA approval for Clobetasol Propionate Ointment used for treatment of various skin conditions. The approved product is a generic version of […]
USFDA
Mylan and Biocon receives USFDA approval for BLA for MYL-1401H
Mylan Pharma has received USFDA approval for its biologics licence application (BLA) for MYL-1401H, a proposed biosimilar Pegfilgrastim. The proposed biosimilar Pegfilgrastim is one of […]
Zydus Cadila receives USFDA approval for fluconazole
Zydus Cadila has received final USFDA approval to market fluconazole tablets used for the treatment of fungal infections in USA market. The company also received […]
Lupin receives USFDA approval for triamcinolone acetonide cream
Lupin has received final approval from USFDA to market its generic version of Mylan’s triamcinolone acetonide cream used for treatment of skin disease. The approval […]
Natco receives USFDA approval for Armodafinil
Natco Pharma has received final USFDA approval for generic Armodafinil tablets, used as wakefulness promoting agent. The company plans to market the same in US […]
Alembic Pharma receives USFDA approval for Zolmitriptan
Alembic Pharmaceuticals has received USFDA approval for Zolmitriptan Orally Disintegrating tablets, used for the treatment of migraine, in the American market. The product is therapeutically […]
DRL launches nystatin and triamcinolone acetonide cream in USA
Dr Reddy’s Laboratories Ltd has launched nystatin and triamcinolone acetonide cream USP, in the United States market which has been approved by the USFDA. The […]
Cipla to launch Entecavir tablet in USA
Cipla has received final USFDA approval to market Entecavir tablets used for treatment of Hepatitis B infection. The tablets are generic versions of Bristol-Myers Suibb’s […]
Alembic Pharma receives USFDA approval for Telmisartan and Amlodipine
Alembic Pharmaceuticals has received USFDA approval for its Telmisartan and Amlodipine tablets in the strengths of 40mg/5 mg, 40mg/10 mg, 80mg/5 mg and 80mg/10 mg, […]
Jubilant Life Sciences receives USFDA approval for Darifenacin
Jubilant Life Sciences has received the final USFDA approval for Darifenacin Extended-Release Tablets, used for the treatment of urinary incontinence. The company has received Abbreviated […]